Prevalence and characteristics of neuropsychiatric involvement in an Egyptian cohort of systemic lupus erythematosus patients: a single-center retrospective cohort
Background The aim of this study was to retrospectively investigate the prevalence and characteristics of neuropsychiatric (NP) involvement in a cohort of systemic lupus erythematosus (SLE) patients from a single tertiary center. Results Of 301 included patients’ medical records, the prevalence of N...
Saved in:
Published in | Egyptian Rheumatology and Rehabilitation Vol. 47; no. 1; pp. 18 - 8 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.12.2020
Springer Nature B.V SpringerOpen |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
The aim of this study was to retrospectively investigate the prevalence and characteristics of neuropsychiatric (NP) involvement in a cohort of systemic lupus erythematosus (SLE) patients from a single tertiary center.
Results
Of 301 included patients’ medical records, the prevalence of NPSLE, that was defined according to the American College of Rheumatology Nomenclature of 1999, was 33.5% (101/301), of whom 10 (9.9%) were males. The mean age at the last visit of patients with NP involvement was 29.1 ± 8.2 years, whereas the mean age at onset was 21.9 ± 7.3 years, and the mean disease duration was 89.8 ± 59.4 months. The most common NP manifestations were psychosis [34/101 (33.7%)], followed by seizures [22/101 (21.8%)]. Compared to those without NPSLE, patients with NP involvement were characterized by having a younger age of onset (
p
< 0.001) had a longer disease duration (
p
= 0.02). Of the cumulative characteristics recorded, NPSLE patients showed a higher prevalence of cutaneous vasculitis (
p
= 0.002), discoid rash (
p
= 0.03), pleurisy and pleural effusion (
p
= 0.004,
p
= 0.03, respectively), pericarditis (
p
= 0.007), thrombocytopenia (
p
= 0.04), and secondary antiphospholipid (APS) (
p
= 0.04); however, there was no difference in any of the included serologic features between the two groups. Patients with NPSLE had a higher median disease activity score [Systemic Lupus Erythematosus Disease Activity Index-2 K (SLEDAI-2 K)] at the disease onset (
p
= 0.008), yet it was comparable to those without NP involvement at the last visit (
p
= 0.3). NPSLE patients demonstrated a higher median damage score (
p
< 0.001) that was assessed according to the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) score. NPSLE patients with secondary APS showed a higher prevalence of cerebrovascular accidents (CVA) (
p
< 0.001), while those without APS developed psychosis more frequently (
p
= 0.03).
Conclusion
Neuropsychiatric SLE patients (33.5%) demonstrated a younger age of onset, higher prevalence of secondary APS and distinct clinical characteristics, and had higher disease damage. APS-positive NPSLE patients had a higher prevalence of CVA, while APS-negative patients showed a higher prevalence of psychosis. |
---|---|
AbstractList | Abstract Background The aim of this study was to retrospectively investigate the prevalence and characteristics of neuropsychiatric (NP) involvement in a cohort of systemic lupus erythematosus (SLE) patients from a single tertiary center. Results Of 301 included patients’ medical records, the prevalence of NPSLE, that was defined according to the American College of Rheumatology Nomenclature of 1999, was 33.5% (101/301), of whom 10 (9.9%) were males. The mean age at the last visit of patients with NP involvement was 29.1 ± 8.2 years, whereas the mean age at onset was 21.9 ± 7.3 years, and the mean disease duration was 89.8 ± 59.4 months. The most common NP manifestations were psychosis [34/101 (33.7%)], followed by seizures [22/101 (21.8%)]. Compared to those without NPSLE, patients with NP involvement were characterized by having a younger age of onset (p < 0.001) had a longer disease duration (p = 0.02). Of the cumulative characteristics recorded, NPSLE patients showed a higher prevalence of cutaneous vasculitis (p = 0.002), discoid rash (p = 0.03), pleurisy and pleural effusion (p = 0.004, p = 0.03, respectively), pericarditis (p = 0.007), thrombocytopenia (p = 0.04), and secondary antiphospholipid (APS) (p = 0.04); however, there was no difference in any of the included serologic features between the two groups. Patients with NPSLE had a higher median disease activity score [Systemic Lupus Erythematosus Disease Activity Index-2 K (SLEDAI-2 K)] at the disease onset (p = 0.008), yet it was comparable to those without NP involvement at the last visit (p = 0.3). NPSLE patients demonstrated a higher median damage score (p < 0.001) that was assessed according to the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) score. NPSLE patients with secondary APS showed a higher prevalence of cerebrovascular accidents (CVA) (p < 0.001), while those without APS developed psychosis more frequently (p = 0.03). Conclusion Neuropsychiatric SLE patients (33.5%) demonstrated a younger age of onset, higher prevalence of secondary APS and distinct clinical characteristics, and had higher disease damage. APS-positive NPSLE patients had a higher prevalence of CVA, while APS-negative patients showed a higher prevalence of psychosis. Background The aim of this study was to retrospectively investigate the prevalence and characteristics of neuropsychiatric (NP) involvement in a cohort of systemic lupus erythematosus (SLE) patients from a single tertiary center. Results Of 301 included patients’ medical records, the prevalence of NPSLE, that was defined according to the American College of Rheumatology Nomenclature of 1999, was 33.5% (101/301), of whom 10 (9.9%) were males. The mean age at the last visit of patients with NP involvement was 29.1 ± 8.2 years, whereas the mean age at onset was 21.9 ± 7.3 years, and the mean disease duration was 89.8 ± 59.4 months. The most common NP manifestations were psychosis [34/101 (33.7%)], followed by seizures [22/101 (21.8%)]. Compared to those without NPSLE, patients with NP involvement were characterized by having a younger age of onset ( p < 0.001) had a longer disease duration ( p = 0.02). Of the cumulative characteristics recorded, NPSLE patients showed a higher prevalence of cutaneous vasculitis ( p = 0.002), discoid rash ( p = 0.03), pleurisy and pleural effusion ( p = 0.004, p = 0.03, respectively), pericarditis ( p = 0.007), thrombocytopenia ( p = 0.04), and secondary antiphospholipid (APS) ( p = 0.04); however, there was no difference in any of the included serologic features between the two groups. Patients with NPSLE had a higher median disease activity score [Systemic Lupus Erythematosus Disease Activity Index-2 K (SLEDAI-2 K)] at the disease onset ( p = 0.008), yet it was comparable to those without NP involvement at the last visit ( p = 0.3). NPSLE patients demonstrated a higher median damage score ( p < 0.001) that was assessed according to the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) score. NPSLE patients with secondary APS showed a higher prevalence of cerebrovascular accidents (CVA) ( p < 0.001), while those without APS developed psychosis more frequently ( p = 0.03). Conclusion Neuropsychiatric SLE patients (33.5%) demonstrated a younger age of onset, higher prevalence of secondary APS and distinct clinical characteristics, and had higher disease damage. APS-positive NPSLE patients had a higher prevalence of CVA, while APS-negative patients showed a higher prevalence of psychosis. Abstract Background The aim of this study was to retrospectively investigate the prevalence and characteristics of neuropsychiatric (NP) involvement in a cohort of systemic lupus erythematosus (SLE) patients from a single tertiary center. Results Of 301 included patients’ medical records, the prevalence of NPSLE, that was defined according to the American College of Rheumatology Nomenclature of 1999, was 33.5% (101/301), of whom 10 (9.9%) were males. The mean age at the last visit of patients with NP involvement was 29.1 ± 8.2 years, whereas the mean age at onset was 21.9 ± 7.3 years, and the mean disease duration was 89.8 ± 59.4 months. The most common NP manifestations were psychosis [34/101 (33.7%)], followed by seizures [22/101 (21.8%)]. Compared to those without NPSLE, patients with NP involvement were characterized by having a younger age of onset ( p < 0.001) had a longer disease duration ( p = 0.02). Of the cumulative characteristics recorded, NPSLE patients showed a higher prevalence of cutaneous vasculitis ( p = 0.002), discoid rash ( p = 0.03), pleurisy and pleural effusion ( p = 0.004, p = 0.03, respectively), pericarditis ( p = 0.007), thrombocytopenia ( p = 0.04), and secondary antiphospholipid (APS) ( p = 0.04); however, there was no difference in any of the included serologic features between the two groups. Patients with NPSLE had a higher median disease activity score [Systemic Lupus Erythematosus Disease Activity Index-2 K (SLEDAI-2 K)] at the disease onset ( p = 0.008), yet it was comparable to those without NP involvement at the last visit ( p = 0.3). NPSLE patients demonstrated a higher median damage score ( p < 0.001) that was assessed according to the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) score. NPSLE patients with secondary APS showed a higher prevalence of cerebrovascular accidents (CVA) ( p < 0.001), while those without APS developed psychosis more frequently ( p = 0.03). Conclusion Neuropsychiatric SLE patients (33.5%) demonstrated a younger age of onset, higher prevalence of secondary APS and distinct clinical characteristics, and had higher disease damage. APS-positive NPSLE patients had a higher prevalence of CVA, while APS-negative patients showed a higher prevalence of psychosis. BackgroundThe aim of this study was to retrospectively investigate the prevalence and characteristics of neuropsychiatric (NP) involvement in a cohort of systemic lupus erythematosus (SLE) patients from a single tertiary center.ResultsOf 301 included patients’ medical records, the prevalence of NPSLE, that was defined according to the American College of Rheumatology Nomenclature of 1999, was 33.5% (101/301), of whom 10 (9.9%) were males. The mean age at the last visit of patients with NP involvement was 29.1 ± 8.2 years, whereas the mean age at onset was 21.9 ± 7.3 years, and the mean disease duration was 89.8 ± 59.4 months. The most common NP manifestations were psychosis [34/101 (33.7%)], followed by seizures [22/101 (21.8%)]. Compared to those without NPSLE, patients with NP involvement were characterized by having a younger age of onset (p < 0.001) had a longer disease duration (p = 0.02). Of the cumulative characteristics recorded, NPSLE patients showed a higher prevalence of cutaneous vasculitis (p = 0.002), discoid rash (p = 0.03), pleurisy and pleural effusion (p = 0.004, p = 0.03, respectively), pericarditis (p = 0.007), thrombocytopenia (p = 0.04), and secondary antiphospholipid (APS) (p = 0.04); however, there was no difference in any of the included serologic features between the two groups. Patients with NPSLE had a higher median disease activity score [Systemic Lupus Erythematosus Disease Activity Index-2 K (SLEDAI-2 K)] at the disease onset (p = 0.008), yet it was comparable to those without NP involvement at the last visit (p = 0.3). NPSLE patients demonstrated a higher median damage score (p < 0.001) that was assessed according to the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) score. NPSLE patients with secondary APS showed a higher prevalence of cerebrovascular accidents (CVA) (p < 0.001), while those without APS developed psychosis more frequently (p = 0.03).ConclusionNeuropsychiatric SLE patients (33.5%) demonstrated a younger age of onset, higher prevalence of secondary APS and distinct clinical characteristics, and had higher disease damage. APS-positive NPSLE patients had a higher prevalence of CVA, while APS-negative patients showed a higher prevalence of psychosis. |
ArticleNumber | 18 |
Author | M Medhat, Basma Eissa, Mervat Moghazy, Abdelkawy |
Author_xml | – sequence: 1 givenname: Basma surname: M Medhat fullname: M Medhat, Basma email: basmamedhat@kasralainy.edu.eg organization: Rheumatology and Rehabilitation department, Faculty of Medicine, Cairo University – sequence: 2 givenname: Abdelkawy surname: Moghazy fullname: Moghazy, Abdelkawy organization: Rheumatology and Rehabilitation department, Faculty of Medicine, Cairo University – sequence: 3 givenname: Mervat surname: Eissa fullname: Eissa, Mervat organization: Rheumatology and Rehabilitation department, Faculty of Medicine, Cairo University |
BookMark | eNp9kc1u1DAUhS1UJIbSF2AViXXAP4mTsENVKZUqwQIkdtadm-sZjzJ2sD0j5Xl4UTxNBTvkhe-1z3f8c16zKx88MfZW8PdC9PpDapTQuuaS15xzoWv1gm0kH3itpGqv2EYIwWuhxc9X7Calw0XUat5ztWG_v0U6w0QeqQI_VriHCJgpupQdpirYytMphjktuHeQo8PK-XOYznQkn0tdsOput8zZlQLDPsR8odKSMh2LejrNp1RRXPKejpBDKt0M2RU6faygSs7vJqqx9BSrSDmGNBNmd6ZnuzfspYUp0c3zfM1-fL77fvulfvx6_3D76bFG2TWqBmzl2LRiO7SD5IAwqu1Wj5qsHTplQVgJpEGXTWtxGMvOgC0SB9kMiL26Zg-r7xjgYObojhAXE8CZp4UQdwZi-ZWJjB2bEblulKUCK7lF26uuG8QI2DctFa93q9ccw68TpWwO4RR9ub6RXd83qoyuqOSqwvLoFMn-PVVwc8nWrNmakq15ytaoAqkVSkXsdxT_Wf-H-gMBsq7H |
CitedBy_id | crossref_primary_10_1186_s41983_022_00464_y |
Cites_doi | 10.1177/0961203317751856 10.1002/art.34473 10.1002/art.1780390303 10.1136/ard.2008.106351 10.1093/rheumatology/ker310 10.5402/2012/989218 10.1016/j.semarthrit.2012.03.011 10.5606/ArchRheumatol.2014.4051 10.1177/0961203318776085 10.1002/art.1780250601 10.4103/0972-2327.64633 10.4103/err.err_46_17 10.1177/0961203306073133 10.2147/OARRR.S9711 10.4103/2277-9175.178795 10.1136/annrheumdis-2018-eular.6883 10.1111/j.1538-7836.2006.01753.x 10.1212/WNL.57.3.496 10.1111/1756-185X.12213 10.1093/rheumatology/41.11.1308 |
ContentType | Journal Article |
Copyright | The Author(s) 2020 The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2020 – notice: The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION 3V. 7RV 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. KB0 M0S NAPCQ PIMPY PQEST PQQKQ PQUKI PRINS DOA |
DOI | 10.1186/s43166-020-00016-3 |
DatabaseName | Springer Nature OA Free Journals CrossRef ProQuest Central (Corporate) ProQuest Nursing and Allied Health Journals Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) Nursing & Allied Health Premium Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central Nursing & Allied Health Premium ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | CrossRef Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2090-3235 |
EndPage | 8 |
ExternalDocumentID | oai_doaj_org_article_fd4dc0643fe24932bcf837791dac845e 10_1186_s43166_020_00016_3 |
GroupedDBID | 5VS 7RV 7X7 8FI 8FJ AAFWJ AAKKN AAYZJ ABUWG ABXLX ACACY ACGFS ADBBV AFKRA AFNRJ AFPKN AHBXF ALMA_UNASSIGNED_HOLDINGS BAPOH BCNDV BENPR C24 C6C CCPQU EBS EIHBH FYUFA GROUPED_DOAJ HMCUK IAO IEA IHR IHW IPNFZ ITC KQ8 NAPCQ OVD PIMPY RIG RMW RSV SOJ TEORI UKHRP 0R~ AAYXX ABEEZ ACULB AFGXO ALIPV CITATION 3V. 7XB 8FK AZQEC DWQXO K9. PQEST PQQKQ PQUKI PRINS |
ID | FETCH-LOGICAL-c2743-ac52d451b95920acad3bb6d6eff973fa1f2ae6a6920ffc9dd6e9c5ce0a249cc83 |
IEDL.DBID | DOA |
ISSN | 1110-161X |
IngestDate | Thu Jul 04 21:01:21 EDT 2024 Wed Sep 25 01:13:35 EDT 2024 Thu Sep 26 18:16:38 EDT 2024 Sat Dec 16 12:01:36 EST 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Neuropsychiatric Disease activity Systemic lupus erythematosus Egyptian Disease damage Antiphospholipid syndrome |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c2743-ac52d451b95920acad3bb6d6eff973fa1f2ae6a6920ffc9dd6e9c5ce0a249cc83 |
OpenAccessLink | https://doaj.org/article/fd4dc0643fe24932bcf837791dac845e |
PQID | 2788434347 |
PQPubID | 5642834 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_fd4dc0643fe24932bcf837791dac845e proquest_journals_2788434347 crossref_primary_10_1186_s43166_020_00016_3 springer_journals_10_1186_s43166_020_00016_3 |
PublicationCentury | 2000 |
PublicationDate | 20201201 |
PublicationDateYYYYMMDD | 2020-12-01 |
PublicationDate_xml | – month: 12 year: 2020 text: 20201201 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Cairo |
PublicationTitle | Egyptian Rheumatology and Rehabilitation |
PublicationTitleAbbrev | Egypt Rheumatol Rehabil |
PublicationYear | 2020 |
Publisher | Springer Berlin Heidelberg Springer Nature B.V SpringerOpen |
Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V – name: SpringerOpen |
References | HanlyJGUrowitzMBSuLBaeSCGordonCWallaceDJClarkeABernatskySIsenbergDRahmanAAlarcónGSProspective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosusAnnals of the rheumatic diseases2010695295351:STN:280:DC%2BC3c7pt1aqtg%3D%3D10.1136/ard.2008.106351 Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29:288–291 AinialaHLoukkolaJPeltolaJKorpelaMHietaharjuAThe prevalence of neuropsychiatric syndromes in systemic lupus erythematosusNeurology2001574965001:STN:280:DC%2BD3MvlslWqtw%3D%3D10.1212/WNL.57.3.496 Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Sanchez- Guerrero J, Urowitz M, Bacon P, Bombardieri S, Hanly J, Jones J (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum; 39:363–369. Hafez N, Soltan L, Abo ray AA (2007) Study of neuropsychiatric manifestations and immunological markers in systemic lupus erythematosus, Egypt J. Neurol Psychiat. Neurosurg; 44:333–343 ShehataGAAbdel-KareemMISubclinical cerebrovascular cognitive function, and mood changes in patients with systemic lupus erythematosusOpen access rheumatology: research and reviews201021710.2147/OARRR.S9711 MahmoudGAShahinAAZayedHSMoghazyAEissaBMClinical and immunological pattern and outcome of Egyptian systemic lupus erythematosus patients: a single center experienceLupus201827156215691:STN:280:DC%2BC1MflvFOrug%3D%3D10.1177/0961203318776085 Eissa M, Medhat B, Moghazy (2018) AAB0606 Neuropsychiatric lupus in a sample of egyptian patients with systemic lupus erythematosus: prevalence and clinical characteristics. Ann Rheum Dis 77:1454. Petri M, Orbai AM, Alarco´ n GS, et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum; 64:2677–2686. GovoniMBombardieriSBortoluzziACaniattiLCasuCContiFDe VitaSDoriaAFarinaIFerraccioliGGremeseEFactors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patientsRheumatology20125115716810.1093/rheumatology/ker310 Morad CS, Mansour HE, Ibrahim SE, Ahmad KA, Arafa SG. Subclinical neuropsychiatric dysfunctions in female patients with systemic lupus erythematosus (2018) Egyptian Rheumatology and Rehabilitation; 45:49. LiangMHCorzilliusMBaeSCLewRAFortinPRGordonCIsenbergDAlarcónGSStraatonKVDenburgJDenburgSThe American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromesArthritis and rheumatism199914599608 MiyakisSLockshinMDAtsumiTInternational consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)J Thromb Haemos200642953061:CAS:528:DC%2BD28XisVSjuro%3D10.1111/j.1538-7836.2006.01753.x Moraes-Fontes MF, Lúcio I, Santos C, Campos MM, Riso N, Vaz Riscado M (2012) Neuropsychiatric features of a cohort of patients with systemic lupus erythematosus. ISRN rheumatology; 20. FanWZhouZLuLChenSBaoCClinical manifestations of neuropsychiatric systemic lupus erythematosus in Chinese patients.Archives of Rheumatology201429889310.5606/ArchRheumatol.2014.4051 KakatiSBarmanBAhmedSUHussainMNeurological manifestations in systemic lupus erythematosus: a single centre study from North East IndiaJournal of clinical and diagnostic research: JCDR20171OC05 Ginzler EM, Diamond HS, Weiner M et al (1982) A multicenter study of outcome in systemic lupus erythematosus. Entry variables as predictors of prognosis. Arthritis Rheum:606–611 Hajighaemi F, Etemadifar M, Bonakdar ZS (2016) Neuropsychiatric manifestations in patients with systemic lupus erythematosus : a study from Iran. Advanced biomedical research; 5. JönsenABengtssonANivedORybergBSturfeltGOutcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortalityRheumatology2002411308131210.1093/rheumatology/41.11.1308 El HadidiKTMedhatBMAbdel BakiNMAbdel KafyHAbdelrahamanWYousriAYCharacteristics of systemic lupus erythematosus in a sample of the Egyptian population: a retrospective cohort of 1109 patients from a single centerLupus2018271030103810.1177/0961203317751856 Abdul-sattar AB, Goda T, Negm MG (2013) Neuropsychiatric manifestations in a consecutive cohort of systemic lupus erythematosus; a single center study, International journal of rheumatic diseases; 16:715–23 HaghighiABHazaSGNeuropsychiatric manifestations of systemic lupus erythematosus : Iranian experienceAnnals of Indian Academy of Neurology20101310810.4103/0972-2327.64633 BernatskySClarkeAGladmanDDMortality related to cerebrovascular disease in systemic lupus erythematosusLupus2006158358391:STN:280:DC%2BD2s%2Fhs1SrsA%3D%3D10.1177/0961203306073133 BorowoyAMPopeJESilvermanEFortinPRPineauCSmithCDNeuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition : results from the 1000 faces of lupus cohortIn Seminars in arthritis and rheumatism20124217918510.1016/j.semarthrit.2012.03.011 JG Hanly (16_CR19) 2010; 69 KT El Hadidi (16_CR16) 2018; 27 16_CR18 M Govoni (16_CR20) 2012; 51 AM Borowoy (16_CR12) 2012; 42 H Ainiala (16_CR4) 2001; 57 16_CR1 GA Shehata (16_CR23) 2010; 2 16_CR7 16_CR8 S Bernatsky (16_CR2) 2006; 15 MH Liang (16_CR3) 1999; 14 16_CR5 A Jönsen (16_CR24) 2002; 41 16_CR9 GA Mahmoud (16_CR17) 2018; 27 W Fan (16_CR10) 2014; 29 S Miyakis (16_CR6) 2006; 4 S Kakati (16_CR15) 2017; 1 16_CR22 AB Haghighi (16_CR11) 2010; 13 16_CR21 16_CR13 16_CR14 |
References_xml | – volume: 27 start-page: 1030 year: 2018 ident: 16_CR16 publication-title: Lupus doi: 10.1177/0961203317751856 contributor: fullname: KT El Hadidi – ident: 16_CR5 doi: 10.1002/art.34473 – ident: 16_CR8 doi: 10.1002/art.1780390303 – volume: 69 start-page: 529 year: 2010 ident: 16_CR19 publication-title: Annals of the rheumatic diseases doi: 10.1136/ard.2008.106351 contributor: fullname: JG Hanly – ident: 16_CR14 – volume: 51 start-page: 157 year: 2012 ident: 16_CR20 publication-title: Rheumatology doi: 10.1093/rheumatology/ker310 contributor: fullname: M Govoni – ident: 16_CR21 doi: 10.5402/2012/989218 – volume: 42 start-page: 179 year: 2012 ident: 16_CR12 publication-title: In Seminars in arthritis and rheumatism doi: 10.1016/j.semarthrit.2012.03.011 contributor: fullname: AM Borowoy – volume: 29 start-page: 88 year: 2014 ident: 16_CR10 publication-title: Archives of Rheumatology doi: 10.5606/ArchRheumatol.2014.4051 contributor: fullname: W Fan – ident: 16_CR7 – volume: 14 start-page: 599 year: 1999 ident: 16_CR3 publication-title: Arthritis and rheumatism contributor: fullname: MH Liang – volume: 27 start-page: 1562 year: 2018 ident: 16_CR17 publication-title: Lupus doi: 10.1177/0961203318776085 contributor: fullname: GA Mahmoud – ident: 16_CR1 doi: 10.1002/art.1780250601 – volume: 1 start-page: OC05 year: 2017 ident: 16_CR15 publication-title: Journal of clinical and diagnostic research: JCDR contributor: fullname: S Kakati – volume: 13 start-page: 108 year: 2010 ident: 16_CR11 publication-title: Annals of Indian Academy of Neurology doi: 10.4103/0972-2327.64633 contributor: fullname: AB Haghighi – ident: 16_CR22 doi: 10.4103/err.err_46_17 – volume: 15 start-page: 835 year: 2006 ident: 16_CR2 publication-title: Lupus doi: 10.1177/0961203306073133 contributor: fullname: S Bernatsky – volume: 2 start-page: 17 year: 2010 ident: 16_CR23 publication-title: Open access rheumatology: research and reviews doi: 10.2147/OARRR.S9711 contributor: fullname: GA Shehata – ident: 16_CR13 doi: 10.4103/2277-9175.178795 – ident: 16_CR9 doi: 10.1136/annrheumdis-2018-eular.6883 – volume: 4 start-page: 295 year: 2006 ident: 16_CR6 publication-title: J Thromb Haemos doi: 10.1111/j.1538-7836.2006.01753.x contributor: fullname: S Miyakis – volume: 57 start-page: 496 year: 2001 ident: 16_CR4 publication-title: Neurology doi: 10.1212/WNL.57.3.496 contributor: fullname: H Ainiala – ident: 16_CR18 doi: 10.1111/1756-185X.12213 – volume: 41 start-page: 1308 year: 2002 ident: 16_CR24 publication-title: Rheumatology doi: 10.1093/rheumatology/41.11.1308 contributor: fullname: A Jönsen |
SSID | ssj0001560803 ssib046616483 ssib050731054 |
Score | 2.1720564 |
Snippet | Background
The aim of this study was to retrospectively investigate the prevalence and characteristics of neuropsychiatric (NP) involvement in a cohort of... Abstract Background The aim of this study was to retrospectively investigate the prevalence and characteristics of neuropsychiatric (NP) involvement in a... BackgroundThe aim of this study was to retrospectively investigate the prevalence and characteristics of neuropsychiatric (NP) involvement in a cohort of... Abstract Background The aim of this study was to retrospectively investigate the prevalence and characteristics of neuropsychiatric (NP) involvement in a... |
SourceID | doaj proquest crossref springer |
SourceType | Open Website Aggregation Database Publisher |
StartPage | 18 |
SubjectTerms | Age Alopecia Anemia Antibodies Antiphospholipid syndrome Autoimmune diseases Baldness Deoxyribonucleic acid Disease activity Disease damage DNA Egyptian Fever Gender Leukopenia Lupus Medical records Medicine Medicine & Public Health Neuropsychiatric Pericarditis Pleural effusion Psychosis Rehabilitation Rheumatology Systemic lupus erythematosus Thrombocytopenia Ulcers |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA_nCeKL-Imrp-TBNy27TdI0uZdD5Y5FOJ882LeSTBM5ONq9tvvg3-M_6kza7rKCvrXNB6EzycxkZn7D2AdX1FJFibaJjJApQJvV2LLIoPSlNN5Yk2osXX_X6xv1bVNsTth6zoWhsMr5TEwHdd0C3ZEvBdpqlAWpyqXzdAsAw_Jie59R_Sjys07FNB6wh7lAtQI5u9zsBatCKaTVQZCiEoRqzSRI53xik8oo495fZagGbeYMG6OXPeWLU6xuSsLOdSaPpFgC-z_SUP9yqiZZdfWUPZmUTP555Ipn7CQ0z9mj68mN_oL9JuAml9KNuGtqDseozbyNPOFc7kOhb4HfNniQJXDxAZ9xGL-kCmbIXZyK7HYDjRpxobH33W6763nofo2gsG2PbxOEa3_OHacbiruQUWho6HgXhq6dcz6n6V6ym6vLH1_X2VStIQNBOKcOClGrIve2sGLlwNXSe13rEKMtZXR5FC5op7ExRrA1tlgoIKwcWoAARr5ip03bhNeMS3DBeR-Ry61SqrRowovSaSgNDrdiwT7Of7_ajqAcVTJmjK5GWlVIq-RX15VcsC9EoH1PAtROH9ruZzXtzyrWqgZSz2LA5UjhIRrCYsxrB0YVYcHOZvJW0y7vqwNPLtinmeSH5n8v6c3_Z3vLHgtithQ1c8ZOh24X3qHuM_j3ia3_AMVCAV4 priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSIgL4ikWCvKBG0Rs_DY3WLWqkMqJSnuL7LEtVaqyVZI99PfwRxk7TssiOHBLYjuxMjOZmczMN4S8dzJwkTj6JjxBIwB9VmO1bEB7zY031pQeS-ff1dmF-LaV2wqTk2thfo_ft0Z9GnOpdk6TLfXPrWr4ffJAopmShXCjNgvvCNQzStypSjRz0HCpqnKpGDalUTJK97rBO2yXGpq_PuZATxU4_wMb9I-wadFGp0_I42pG0i8z3Z-Se7F_Rh6e10D5c_IzQzO5UlBEXR8oHOIy012iBcnyNtn5Euhlj5-qAh8-4TEuoye5RxnyD81tdIcpr5qRn3H21f56P9I43Mywr7sRzypI6_iZOpr_QVzFJid_xoEOcRp2S1Vnvd0LcnF68mNz1tR-DA2wjGTqQLIgZOuttGztwAXuvQoqpmQ1T65NzEXlFA6mBDbgiAUJce3QxwMw_CU56nd9fEUoBxed9wn52AohtEUnnWmnQBtcbtmKfFjefnc9w250xV0xqptp1SGtSuRcdXxFvmYC3c7MkNnlAnJSVyWwS0EEyAZYirgdzjwkk9EW2-DACBlX5Hghb1fleOyYNibX3gq9Ih8Xkt8N_3tLr_9v-hvyiGXmK3kyx-RoGvbxLVo7k39X2PwXRu72RQ priority: 102 providerName: Springer Nature |
Title | Prevalence and characteristics of neuropsychiatric involvement in an Egyptian cohort of systemic lupus erythematosus patients: a single-center retrospective cohort |
URI | https://link.springer.com/article/10.1186/s43166-020-00016-3 https://www.proquest.com/docview/2788434347/abstract/ https://doaj.org/article/fd4dc0643fe24932bcf837791dac845e |
Volume | 47 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBZtCqWX0ifdNFl06K01Weut3JJlQygklNLA3oSeEAjeYHsP_T39oxnJdpItlFx6MZYlGVkz0sxYM98g9MXyQFmiYJvQ5CvmwWZVWvLKSyepckqrkmPp4lKcX7Hva75-lOor-4QN8MDDxB2lwILPcjNFsBQocT6pDJJXB-sV47HsvjV_ZEwBJzGQOoI9CE5QekCNGQXnFD-sStpkWOuLCtSe9RRRo8RRl-PDs29uCbquRUV3pFYB99_RSP86RC2y6ewNej0qlfhk-Ji36Fls3qGXF-Ox-Xv0JwM12RJehG0TsN9FacabhAuu5b3r87XH1w1sXAVMvId76IZXOWMZcBPOSXXbPvcacKCh9c32dtvh2P4eQGA3HZRGyNbuGFuc_0jcxCq7gsYWt7FvN1OM5_i6D-jqbPVreV6N2RkqTzKuqfWcBMZrp7kmC-ttoM6JIGJKWtJk60RsFFZAZUpeB6jRnvu4sEBH7xX9iPaaTRM_IUy9jda5BFytGWNSg8lOpBVeKuiuyQx9nWbf3A4gHKYYL0qYgVYGaFXO0YWhM3SaCXTfMgNolwfAVmZkK_MUW83QwUReM67qzhCpVI7EZXKGvk0kf6j-95D2_8eQPqNXJLNk8aU5QHt9u42HoBH1bo6ey7Wcoxenq8sfP6G0JCxfxXJelsUdCK0KzA |
link.rule.ids | 315,786,790,870,2115,12083,21416,27957,27958,31754,33779,41154,41155,42223,42224,43345,43840,51611,52268,74102,74659 |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELZgkYAL4ikKC_jADaJtbcexuSBAuyqw3dOu1JvljG200iopSXrg9_BHGTtOqyLBLYkfsjJjz4xn5htC3trScRE42iY8QCEAbValq7KAqq64qpVWqcbS6kIur8S3dbnOF259DquczsR0ULsW4h35CUNbLWZBiurj5mcRq0ZF72ouoXGb3BGcixjSV6134lSg7JFiLz5R9UFlJovPKYtYpeLJuOPnBSo_6ymvRsmTPmaJxwjdlHq9kAU_kF0J4v9AL_3LlZok1NlD8iCrlvTTyAuPyC3fPCZ3V9l5_oT8jnBNNiUZUds4CodYzbQNNKFb7gKgr4FeN3h8JUjxAZ9xGD2NdcuQp2gsrdsNcdSIBo29b7abbU9992uEgm17fMvArf0Hamm8l7jxRQwI9R3t_NC1U6Znnu4puTo7vfyyLHKNhgJYRDe1UDInykWtS83mFqzjdS2d9CHoige7CMx6aSU2hgDaYYuGEvzcot0HoPgzctS0jX9OKAfrbV0H5G0thKg0Gu6sshIqhcM1m5F30983mxGKwyQTRkkz0sogrZI3XRo-I58jgXY9I4x2-tB2P0zelSY44SAqZcHjcjirIaiIwLhwFpQo_YwcT-Q1eW_3Zs-JM_J-Ivm--d9LevH_2d6Qe8vL1bk5_3rx_SW5zyLjpbiZY3I0dFv_CrWfoX6dWPwPn2UAkQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELaglSouiKdYWsAHbhDtbuw4NhdEYVfl0VWFqLQ3yxnbqFKVLEn20N_DH2XsOF0tEtyS-KEo89kzE898Q8hrU1jGPUPfhHnIOKDPKlVZZFBWJZOVVDLWWDpfibNL_mVdrFP8U5fCKsc9MW7UtoHwj3yao68WsiB5OfUpLOLi0_L95lcWKkiFk9ZUTuMuOSy5KBDhh6eL1cX3EV0cNZHgO2WKhhCaNkmZjjnFMpZSxvU_y9AUWo9ZNlJMu5AzHuJ1YyL2XGRsT5NFwv89K_Wvg9Wor5YPyP1kaNIPAzIekjuufkSOztNR-mPyO5A3mZhyRE1tKewzN9PG08h1eRsOfQX0qsbNLBKM93iNw-giVDFDhNFQaLftw6iBGxp7X28324669mYghm06vEs0rt07amj4S3HtshAe6lraur5txrzPNN0Tcrlc_Ph4lqWKDRnkgevUQJFbXswrVah8ZsBYVlXCCue9Kpk3c58bJ4zARu9BWWxRUICbGfQCASR7Sg7qpnbPCGVgnKkqj0hXnPNSoRufl0ZAKXG4yifkzfj19WYg5tDRoZFCD7LSKKt4ti40m5DTIKDbnoFUOz5o2p86rVHtLbcQTDTv8HVYXoGXgY9xbg1IXrgJORnFq9NK7_QOlxPydhT5rvnfr_T8_7O9IkeIb_3t8-rrMbmXB9zFIJoTctC3W_cCTaG-epkw_gc4ogY0 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+and+characteristics+of+neuropsychiatric+involvement+in+an+Egyptian+cohort+of+systemic+lupus+erythematosus+patients%3A+a+single-center+retrospective+cohort&rft.jtitle=Egyptian+Rheumatology+and+Rehabilitation&rft.au=Basma+M+Medhat&rft.au=Abdelkawy+Moghazy&rft.au=Mervat+Eissa&rft.date=2020-12-01&rft.pub=SpringerOpen&rft.issn=1110-161X&rft.eissn=2090-3235&rft.volume=47&rft.issue=1&rft.spage=1&rft.epage=8&rft_id=info:doi/10.1186%2Fs43166-020-00016-3&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_fd4dc0643fe24932bcf837791dac845e |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1110-161X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1110-161X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1110-161X&client=summon |